Startle responses to electric shocks: Measurement of shock sensitivity and effects of morphine, buspirone and brain lesions

Chinese Journal of Physiology

Volumn 43, Issue 1, 2000, Pages 35-47

  Chen, Der Yow ^a   Ho, Shao Hsuan ^a   Liang, K C ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Acoustic startle; Amygdala; Insular cortex; Naloxone; Nociception; Ventral posterior nucleus of thalamus

Indexed keywords

BUSPIRONE; MORPHINE; NALOXONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; CINGULATE GYRUS; ELECTRIC SHOCK; INSULA; MALE; MOTOR PERFORMANCE; NOCICEPTION; NONHUMAN; PREFRONTAL CORTEX; RADIOFREQUENCY; RAT; STARTLE REFLEX; THALAMUS NUCLEUS;

EID: 0034032122     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (74)

1. Aguilar, M.A., Minarro, J. and Simon, V.M. Dose-dependent impairing effects of morphine on avoidance acquisition and performance in male mice. Neurobiol. Learn. Mem. 69: 92-105, 1998.
2. Becker, A., Letzel, K., Letzel, U. and Grecksch, G. Kindling of the dorsal and the ventral hippocampus: effects on learning performance in rats. Physiol. Behav. 62: 1265-71, 1997.
3. Berge, O.G., Hole, K. and Ogren, S.O. Attenuation of morphine-induced analgesia by p-chlorophenylalanine and p-chloroamphetamine: test-dependent effects and evidence for brainstem 5-hydroxytryptamine involvement. Brain Res. 271: 51-64, 1983.
4. Bermudez-Rattoni, R, Introini-Collison, I., Coleman-Mesches, K. and McGaugh, J.L. Insular cortex and amygdala lesions induced after aversive training impair retention: effects of degree of training. Neurobiol. Learn. Mem. 67: 57-63, 1997.
5. Bernard, J.F. and Besson, J.M. The spino(trigemino) pontoamygdaloid pathway: electrophysiological evidence for an involvement in pain processes. J. of Neurophysiol. 63: 473-90, 1990.
6. Bernard, J.F., Bester, H. and Besson, J.M. Involvement of the spinoparabrachio -amygdaloid and -hypothalamic pathways in the autonomic and affective emotional aspects of pain. Prog. Brain Res. 107: 243-55, 1996.
7. Bloss, J.L. and Hammond, D.L. Shock titration in the rhesus monkey: effects of opiate and nonopiate analgesics. J. Pharmacol. Exp. Ther. 235: 423-30, 1985.
8. Bonnet, K.A. and Peterson, K.E. A modification of the jump-flinch technique for measuring pain sensitivity in rats. Pharmacol. Biochem. Behav. 3: 47-55, 1975.
9. Bragin, E.O., Korneev, A.Y. and Vasilenko, G.F. Buspirone effect on the development of antinociceptive reactions. Pain 36: 257-61, 1989.
10. Bubser, M. and Koch, M. Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex. Psychopharmacol. 113: 487-92, 1994.
11. Burkey, A.R., Carstens, E., Wenniger, J.J., Tang, J. and Jasmin, L. An opioidergic cortical antinociception triggering site in the agranular insular cortex of the rat that contributes to morphine antinociception. J. Neurosci. 16: 6612-23, 1996.
12. Craft, R.M. and Dykstra, L.A. Differential cross-tolerance to opioids in squirrel monkeys responding under a shock titration schedule. J. Pharmacol. Exp. Ther. 252: 945-52, 1990.
13. Crocker, A.D. and Russell, R.W. The up-and-down method for the determination of nociceptive thresholds in rats. Pharmacol. Biochem. Behav. 21: 133-6, 1984.
14. Davis, M. Morphine and naloxone: effects on conditioned fear as measured with the potentiated startle paradigm. Eur. J. Pharmacol. 54: 341-7, 1979.
15. Davis, M. Neurochemical modulation of sensory-motor reactivity: acoustic and tactile startle reflexes. Neurosci. Biobehav. Rev. 4: 241-63, 1980.
16. Davis, M., The mammalian startle response. In R.C. Eaton (Ed.), Neural mechanisms of startle behavior. New York: Plenum Press, pp. 287-351, 1984.
17. Davis, M. Animal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect. Pharmacol. Ther. 47: 147-65, 1990.
18. Davis, M., Cassella, J.V., Wrean, W.H. and Kehne, J.H. Serotonin receptor subtype agonists: differential effects on sensorimotor reactivity measured with acoustic startle. Psychophannacol. Bull. 22: 837-43, 1986.
19. Davis, M., Falls, W.A., Campeau, S. and Kim, M. Fear-potentiated startle: a neural and pharmacological analysis. Behav. Brain Res. 58: 175-98, 1993.
20. Davis, M., Gendelman, D.S., Tischler, M.D. and Gendelman, P.M. A primary acoustic startle circuit: lesion and stimulation studies. J. Neurosci. 2: 791-805, 1982.
21. Dennis, S.G. and Melzac, R., Comparison of phasic and tonic pain in animals. In J.J. Bonica, Liebeskind, J.C. and Albe-Fessard, D. (Eds.), Advances in pain research and therapy, Vol. 3. New York: Raven press, 1979.
22. 2 antagonists. Psychopharmacol. 112: 116-20, 1993.
23. Engberg, G. A metabolite of buspirone increases locus coeruleus activity via alpha 2-receptor blockade. J. Neural Trans. 76:91-98, 1989.
24. Gewirtz, J.C., McNish, K.A. and Davis, M. Lesions of the bed nucleus of the stria terminalis block sensitization of the acoustic startle reflex produced by repeated stress, but not fear-potentiated startle. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 22: 625-48, 1998.
25. Geyer, M.A. and Tapson, G.S. Habituation of tactile startle is altered by drugs acting on serotonin-2 receptors. Neuropsychopharmacol. 1: 135-47, 1988.
26. Giesler, G.J. Evidence of direct nociceptive projecitons from the spinal cord to the hypothalamus and telencephalon. Seminar Neurosci. 7: 253-261, 1995.
27. Giordano, J. and Rogers, L. Antinociceptive effects of the novel anxiolytic buspirone in three pain tests in rats. Pain 39: 109-13, 1989.
28. Hardy, S.G. Analgesia elicited by prefrontal stimulation. Brain Res. 339: 281-4, 1985.
29. Helmstetter, F.J. and Bellgowan, P.S. Lesions of the amygdala block conditional hypoalgesia on the tail flick test. Brain Res. 612: 253-7, 1993.
30. Helmstetter, F.J., Tershner, S.A., Poore, L.H. and Bellgowan, P.S. Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla. Brain Res. 779: 104-18, 1998.
31. Hitchcock, J.M., Sananes, C.B. and Davis, M. Sensitization of the startle reflex by footshock: blockade by lesions of the central nucleus of the amygdala or its efferent pathway to the brainstem. Behav. Neurosci. 103: 509-18, 1989.
32. Hoehn-Saric, R., McLeod, D.R. and Glowa, J.R. The effects of NMDA receptor blockade on the acquisition of a conditioned emotional response. Biol. Psychiatry 30: 170-6, 1991.
33. Ito, S.I. Possible representation of somatic pain in the rat insular visceral sensory cortex: a field potential study. Neurosci. Lett. 241: 171-4, 1998.
34. Izquierdo, I., Quillfeldt, J.A., Zanatta, M.S., Quevedo, J., Schaeffer, E., Schmitz, P.K. and Medina, J.H. Sequential role of hippocampus and amygdala, entorhinal cortex and parietal cortex in formation and retrieval of memory for inhibitory avoidance in rats. Eur. J. Neurosci. 9: 786-93, 1997.
35. Joel, D., Tarrasch, R., Feldon, J. and Weiner, I. Effects of electrolytic lesions of the medial prefrontal cortex or its subfields on 4-arm baited, 8-arm radial maze, two-way active avoidance and conditioned fear tasks in the rat. Brain Res. 765: 37-50, 1997.
36. Jones, S.L. Descending noradrenergic influences on pain. Prog. Brain Res. 88: 381-94, 1991.
37. Kehne, J.H., Cassella, J.V. and Davis, M. Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm. Psychopharmacol. 94: 8-13, 1988.
38. Kim, J.J., DeCola, J.P., Landeira-Femandez, J. and Fanselow, M.S. N-methyl-D-aspartate receptor antagonist APV blocks acquisition but not expression of fear conditioning. Behav. Neurosci. 105: 126-33, 1991.
39. Kim, M. and McGaugh, J.L. Effects of intra-amygdala injections of NMDA receptor antagonists on acquisition and retention of inhibitory avoidance. Brain Res. 585: 35-48, 1992.
40. Lacroix, L., Broersen, L.M., Weiner, I. and Feldon, J. The effects of excitotoxic lesion of the medial prefrontal cortex on latent inhibition, prepulse inhibition, food hoarding, elevated plus maze, active avoidance and locomotor activity in the rat. Neuroscience 84: 431-42, 1998.
41. 1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm. Brain Res. 795: 128-36, 1998.
42. LeDoux, J.E., Iwata, J., Cicchetti, P. and Reis, D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J. Neurosci. 8: 2517-29, 1988.
43. Lee, Y., Lopez, D.E., Meloni, E.G. and Davis, M. A primary acoustic startle pathway: obligatory role of cochlear root neurons and the nucleus reticularis pontis caudalis. J. Neurosci. 16: 3775-89, 1996.
44. 1A receptors. Eur. J. Neurosci. 11: 1491-500, 1999.
45. Liang, K.C, Tsui, K.Y., Tyan, Y.M. and Chiang, T.C. Buspirone impaired acquisition and retention in avoidance tasks: involvement of the hippocampus. Chin. J. Physiol. 41: 33-44, 1998.
46. Ma, Y.L., Wang, H.L., Wu, H.C., Wei, C.L. and Lee, E.H. Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits long-term potentiation in rats. Neuroscience 82: 957-67, 1998.
47. Manning, B.H. and Mayer, D.J. The central nucleus of the amygdala contributes to the production of morphine antinociception in the formalin test. Pain 63: 141-52, 1995.
48. Manning, B.H. and Mayer, D.J. The central nucleus of the amygdala contributes to the production of morphine antinociception in the rat tail-flick test. J. Neurosci. 15: 8199-213, 1995.
49. 1A receptor ligands. Eur. J. Pharmacol. 156: 375-83, 1988.
50. Mao, J., Mayer, D.J. and Price, D.D. Patterns of increased brain activity indicative of pain in a rat model of peripheral mononeuropathy. J. Neurosci. 13: 2689-702, 1993.
51. McGaugh, J.L. Dissociating learning and performance: drug and hormone enhancement of memory storage. Brain Res. Bull. 23: 339-45, 1989.
52. McGaugh, J.L., Introini-Collison, I.E., Cahill, L., Kim, M. and Liang, K.C., Involvement of the amygdala in neuromodulatory influences on memory storage. In J.P. Aggleton (Ed.), The amygdala: Neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley-Liss., pp. 431-451, 1992.
53. Melzack, R. and Casey, K.L., Sensory, motivational and central control determinants of pain: A new conceptual model. In D. Kenshalo (Ed.), The skin senses. New York: Charles C. Thomas, pp. 423-439, 1968.
54. Mesches, M.H., Bianchin, M. and McGaugh, J.L. The effects of intra-amygdala infusion of the AMPA receptor antagonist CNQX on retention performance following aversive training. Neurobiol. Learn. Mem. 66: 324-40, 1996.
55. Millan, M.J. Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice. Pain 58: 45-61, 1994.
56. Murphy, A.Z., Murphy, R.M. and Zemlan, F.P. Role of spinal serotonin1 receptor subtypes in thermally and mechanically elicited nociceptive reflexes. Psychopharmacol. 108: 123-30, 1992.
57. Oliveto, A.H. and Dykstra, L.A. Naloxone sensitivity in squirrel monkeys under a schedule of shock titration. Pharmacol. Biochem. Behav. 26: 191-3, 1987.
58. Paxinos, G. and Watson, C. The rat brain in stereotaxic coordinates, compact third edition. Academic Press, San Diego, 1997.
59. Phillips, R.G. and LeDoux, J.E. Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. Behav. Neurosci. 106: 274-85, 1992.
60. Quillfeldt, J.A., Zanatta, M.S., Schmitz, P.K., Quevedo, J., Schaeffer, E., Lima, J.B., Medina, J.H. and Izquierdo, I. Different brain areas are involved in memory expression at different times from training. Neurobiol. Learn. Mem. 66: 97-101, 1996.
61. Rodgers, R.J. and File, S.E. Exploratory behaviour and aversive thresholds following intra-amygdaloid application of opiates in rats. Pharmacol. Biochem. Behav. 11: 505-11, 1979.
62. Romanski, L.M. and LeDoux, J.E. Equipotentiality of thalamo-amygdala and thalamo-cortico-amygdala circuits in auditory fear conditioning. J. Neurosci. 12: 4501-9, 1992.
63. Sananes, C.B. and Davis, M. N-methyl-D-aspartate lesions of the lateral and basolateral nuclei of the amygdala block fear-potentiated startle and shock sensitization of startle. Behav. Neurosci. 106:72-80, 1992.
64. Shi, C. and Davis, M. Pain pathways involved in fear conditioning measured with fear-potentiated startle: lesion studies. J. Neurosci. 19: 420-30, 1999.
65. Shi, C.J. and Cassell, M.D. Cascade projections from somatosensory cortex to the rat basolateral amygdala via the parietal insular cortex. J. Comp. Neurol. 399: 469-91, 1998.
66. Shi, C.J. and Cassell, M.D. Cortical, thalamic, and amygdaloid connections of the anterior and posterior insular cortices. J. Comp. Neurol. 399: 440-68, 1998.
67. Sipes, T.A. and Geyer, M.A. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology 33: 441-8, 1994.
68. Thompson, R.F. and Spencer, W.A. Habituation: a model phenomenon for the study of neuronal substrates of behavior. Psychol. Rev. 73: 16-43, 1966.
69. Vaccarino, A.L. and Melzack, R. Analgesia produced by injection of lidocaine into the anterior cingulum bundle of the rat. Pain 39: 213-9, 1989.
70. Viaud, M.D. and White, N.M. Dissociation of visual and olfactory conditioning in the neostriatum of rats. Behav. Brain Res. 32: 31-42, 1989.
71. Vogt, B.A., Sikes, R.W. and Vogt, L.J., Anterior cingulate cortex and the medial pain system. In B.A. Vogt and Gabriel, M. (Eds.), Neurobiology of cingulate cortex and limbic thalamus: A comprehensive handbook. Boston: Birkhaeuser, pp. 313-344, 1993.
72. Walker, D.L. and Davis, M. Double dissociation between the involvement of the bed nucleus of the stria terminalis and the central nucleus of the amygdala in startle increases produced by conditioned versus unconditioned fear. J. Neurosci. 17: 9375-83, 1997.
73. Werka, T. The effects of the medial and cortical amygdala lesions on post-stress analgesia in rats. Behav. Brain Res. 86: 59-65, 1997.
74. Willis, W.D. and Westlund, K.N. Neuroanatomy of the pain system and of the pathways that modulate pain. J. Clin. Neurophysiol. 14: 2-31, 1997.